Baxter International Inc. logo

Baxter International Inc.

NYSE:BAXLive AI agent

We’re everywhere healthcare happens, and everywhere it’s going.

Investor website: https://baxter.com/

About

We’re everywhere healthcare happens, and everywhere it’s going. With an unmatched portfolio of connected solutions, medical devices and injectable medicines, our team works alongside our customers to provide the essential innovations and support they need to deliver the best patient care possible. From software that helps safeguard care to connected devices that help make life easier for nurses, we’re redefining how care is delivered to make a greater impact around the world. Our commitment to innovation began in the 1930s and continues today as we focus on transforming patient care through connected technologies and solutions.

Verified company data

Shares outstanding
514
Fully diluted shares
520
Projects
["Pharmaceuticals: There’s a pharmacist behind every dose. And behind every pharmacist, there’s Baxter. Found in hospitals and clinics across more than 100 countries, our comprehensive pharmaceuticals portfolio spans injectables, drug compounding technologies, premixed drugs, inhaled anesthetics and IV solutions.\n\nPharmaceutical Solutions: We provide a broad pharmaceutical portfolio designed to simplify workflows, support patient safety and ensure access to essential medications. From ready-to-use premixes to compounding services (Canada only), we help our customers manage complexity and deliver consistent, high-quality care.\n\nPremixed Medications: We offer practical and innovative medications in frozen premixed and ready-to-use premixed formulations, which may help increase hospital efficiency and support patient safety protocols.\n\nAnesthetics: We are a trusted partner in anesthesia, with inhaled anesthetics used in operating rooms worldwide to support safe and effective surgical care.\n\nDrug Compounding: Baxter CIVA has been the pioneer and leader in providing intravenous admixing services in Canada for over 30 years. Our aim is to continuously improve the safety and efficacy of medication preparation and administration.\n\nVials and Injectable Medications: With our proven ability to develop complex formulations, we offer injectables for key therapeutic areas, including anti-infectives, oncology, cardiovascular and opioid reversal."]
Leadership
William A. Ampofo II (Senior Vice President, Parts & Distribution and Supply Chain, Boeing Global Services), Jeffrey (Jay) A. Craig (Former Chair and Chief Executive Officer, Meritor Corporation), Andrew Hider (President and Chief Executive Officer), Michael R. McDonnell (Former Executive Vice President and Chief Financial Officer, Biogen Inc.), Patricia B. Morrison (Former Executive Vice President, Customer Support Services and Chief Information Officer, Cardinal Health Inc.), Nancy M. Schlichting (Former President and Chief Executive Officer, Henry Ford Health System), Brent Shafer (Chair of the Board and Former Chair and Chief Executive Officer, Cerner Corporation), Amy A. Wendell (Former Senior Vice President, Strategy and Business Development and Licensing, Covidien), David S. Wilkes, M.D. (Dean Emeritus of the University of Virginia School of Medicine), James Borzi (Executive Vice President, Chief Supply Chain Officer), Cynthia (Cindy) Carlisle (Executive Vice President and Chief Human Resources Officer), Stacey Eisen (Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation), Julie Foster (President, Front Line Care), Adriana Guiry (Senior Vice President, Baxter Growth & Performance System), Scott Kaplan (Senior Vice President, Quality, Regulatory & Patient Safety), Piero Novello (Senior Vice President and President, International), Charles (Rusty) Patel (Senior Vice President and Chief Information Officer), John Rogers (Executive Vice President and Chief Financial Officer), David S. Rosenbloom (Executive Vice President and General Counsel), Cecilia Soriano (Group President, Infusion Therapies and Platforms), James Teaff (President, Care & Connectivity Solutions), Steve Wallace (President, Advanced Surgery & Commercial Excellence)

Verified data last updated:

Recent filings